Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study To Determine Safety, Tolerability And Efficacy Of Long -Term Oral Lacosamide (LCM) As Adjunctive Therapy In Children With Epilepsy

NCT00938912 is registered in ClinicalTrials.gov with UCB BIOSCIENCES, Inc. as lead sponsor.

NCT NCT00938912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00938912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study To Determine Safety, Tolerability And Efficacy Of Long -Term Oral Lacosamide (LCM) As Adjunctive Therapy In Children With Epilepsy
Lead sponsor
UCB BIOSCIENCES, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 9, 2009
Completion date
May 18, 2021
Enrollment
366 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy